Meckler Jeffrey A 13D and 13G filings for Indaptus Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-26 4:11 pm Purchase |
2024-11-22 | 13D | Indaptus Therapeutics, Inc. INDP |
Meckler Jeffrey A | 875,704 6.900% |
85,106 (+10.76%) |
Filing |
| 2024-10-10 4:10 pm Purchase |
2023-08-04 | 13D | Indaptus Therapeutics, Inc. INDP |
Meckler Jeffrey A | 790,598 7.300% |
790,598 (New Position) |
Filing |